Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Are the BOLD letters telling us that AEMD is NO longer suspended all part of the marketing strategy? In Canada people have speculated that AEMD is a take out candidate for a little known and heavily insider held company called Spectral Medical. They trade on the OTC, but do not allow any news to be shared in America. They currently have 4 FDA approval and a phase 3B for Sepsis where their treatment is being used on a 2 to 1 ratio over the SOC. Does make you wonder, I like the fact this stock is being downplayed too. Zacks and we are NO longer in the penalty box...too funny!
Rob
Cases of the day/week or month...I golfed yesterday and made a par on the first hole, a birdie on the 9th hole, two more pars on the 13th and 14th and.. a birdie on the par 3 17th...
What do we know? I must be a great golfer! ?? or am I?
LOL
20 years without hard data to back efficacy? I recall the German Sepsis trial producing some fascinating numbers. Our resident pretend Dr. Phil hater leads us to believe the beads are magical and the mgmnt holding us back. How might he know how good the beads are? Based on what efficacy do we know the beads work at all? What diagnostic measures the efficacy? At what rate do the cytokines get removed, there are 127 varieties both good and bad, which ones do we take and which ones do we leave? There are a lot of unknowns here, cept fro the steadfast belief from the board regulars that the beads are a wonder...makes me wonder?? Is $8 too low or far too high? Aren't we losing money hand over fist despite running at max capacity? EUA approvals are as common as Hemo's posts...where is the beef here?
Single patient case study release and up $1.50 pre-mkt. This is just one patient! Imagine if we treatment many more...you do the math! Holy cow this is truly a dream stock!!!
Maybe FMC needs hard data to back up claims when selling to health care professionals.
Our lack of a true RCT with proper data is really becoming a problem. It has been about 20 years of sorb development and I am unable to locate compelling RCT data. Fresenius is a world class organisation, they can not sell cusatomers on Andycap handpicked case studies...they tend to be easily selected and of course have NO power.
BTW ..... why am I only able to post 1 comment a day. I fear this site is crooked or rigged. Some concern a group from Canada working to keep EDTXF lower is running this message board. That is clearly disturbing.
Usually true miracles.
WOW!
Almost $2 below money raise. Anyone know who is dumping?
Same litter of kittens TabbycatRob? I really enjoyed the Youtube video it was excellent. I love the new math and the ability to allow for a calculation that equalizes the "sickness" of two groups for comparative purposes. Who needs a retrospective trial when a dummy RCT trial has so much more creative math to help glean the truth about efficacy. I find it much easier to determine the truth about the "kitty litter" here. I'm waiting for my one post restriction to be lifted. Paul Peasrbee? May be kitty kat.....cept Pearsy never really questioned the science, it's all far too easy to blame any real proven lack of efficacy on poor Philip. I like Phil, he is quick witted, a snappy dresser and a helluva CEO in my personal opinion. I just wish we know exactly how well the beads worked and which cytokines were being reduced and at what pace. We need a theranostic approach like EDTXF and proven efficacy and FDA advancement like that tiny little Canadian friend of ours. Ask John, we're tight...really tight ; > ) My real zest for this left when Fresenius packed in the European theater without a second thought....and there they were gone! When there is a sell off, I like to call it a triple ditching....anyone know who was dumping?
Dutch doc says...."we DO need hard data"?
This is shocking!
Compensating for a sicker patient population....
You should try a RCT .... it's the real thing...like Coke
Sounds like creating a "dummy RCT" could be the secret
Are these people for real?
Does John still question the expense of PMX?
This lack of real RCT data and fresh new equalizing math is an embarrassment to me as a shareholder of the company.
Let's talk about the German sepsis trial and our results there in a real RCT.....Ooopps!
We need more data, this would seem completely agreed upon by the handful of real people along with the endless train of alias ID's...that is swell.
I'd be curious how it is that everyone know the filter is great, wonderful, amazing etc....
I wonder why Fresenius let go of the line in the EU?
Maybe the posters here should be sourcing future products for large pharma?
I remain firm with 50 shares but am watching closely, not so much the company, but instead my friends sharing their public opinion of this giant on the edge of greatness. I suspect the Yahoo board shares the same story of wonderful science and poor management? They too should apply to big pharma.
Rob's memory is good but a little short. It went from $15 to $3 because there was false advertising on multiple fronts regarding a big increase in revenue. Sad but true... a debacle or problem with the German salesforce produced results much more worthy of $3 than $15.
This company needs some hard data...RCT data...real data that majors and others can sink their teeth into. the Andycap files just won't cut it moving forward. Based on our revenue and massive net losses, we'll need some real catalysts and soon. I'm down to my last 50 shares and feeling anxious about the drop of near $2 per share since the big raise
Does the new leadership produce efficacious RCT data as part of their arrival. I find this particular character the most telling of the entire production...recall, over and over and over again.. the product is so good it has to be held back by poor mgnment...at least that would seem to be the 5-10 year message on the forums
Hard to understand why Fresenius would not have recognized what Mikeypure36 gleans from the program. Too bad Fresenius let go of this gem for Europe....goes to show you even Mikey can be smarter than big pharma.
I've always hated science...it is meaningless really!
Making rude comments about the CEO is really smoke and mirror activity. There is nothing wrong with him. The real problem is the complete lack of compelling RCT data. There is virtually no hard-core compelling RCT data to support the use of the filter. Do you people really believe Fresenius would have given up on the EU theater if strong science and RCT data backed it's efficacy? Constantly making rude and baseless negative comments about Phil is a strategy to make you believe the magical beads are being held back by poor leadership....a scam of sorts really. Like Mikefakesmith, his story old and boring but what better story than the ease of changing people to allow Jack's seeds to take all shareholders to the promise land....
Pay attention to the most common thread...it's a wonderful product...and we ALL know this because?? Could be a loooong pause before a legit answer.
I think they are publishing the results from the German Sepsis Trial from a few years ago. Hang on to your pants, it could go parabolic. Wait until we get some actual RCT data to show the true efficacy of the beads! Boy o boy Fresenius will be sorry they dumped the entire EU opportunity back on our laps. Remind me again who picked up that massive revenue opp? I'm sure it's a major..but who? Anecdotal case studies just don't cut the mustard in today's world of precision meds, too bad Andy Cap can't work in sales for us.
FWIW...
Cool, 14 filters, sweet for rev-gen. I've said it for years and Dr. Kevin agrees 100% ... we need some form of accurate diagnostic measurement to figure out dosage/usage. You can't treat by feel, it's not a 70 yard wedge shot, it's life and death and precise science is the only answer. Kev is very high on EDTXF right now thanks to their FDA approval for CV19 vs. the EUA handed out to most of the new kids in town. Spectral has the filter, a FDA approved diagnostic to guide therapy and a FDA approval portable pump to deliver the solution. We ALL know or least think the beads are the better mousetrap, but until we have diagnostic measurement to guide and verify, it's just a bunch of kids pretending to be in their 70's telling people a story on the interweb. I still believe and picked up 50 shares yday. OH and GLTA fiends ;) Some speculate that EDTXF and AEMD would form a tight little relationship...but that is just pure guessing...not like the confirmation of greatness we have here.
Dr. Kevin asked me once again about the actual efficacy and 28 day mortality numbers this company has proven up. I told him about Hemo and twin kitty Orangement and the rest of the "litter". He asked me why the German sepsis trial was so disastrous and I explained that the cyto patients were a much sicker group. His response was that a proper RCT evaluates the same level of patient in a random fashion. He told me to take my 100 shares out of the company. I'm still deciding, all this positive discussion and projections of prices closer to $100 makes me want to stick around for the potential. I just wish I could message more than once a day. Too bad the board is so censored. GO CTSO GO!!!
WOW! really huh? I think a completed RCT with real efficacy numbers are the solution and precisely why I continue to hold a full 100 shares. I think Fresenius shows real interest once the RCT produces real data. Anyone know when the suspension of the current REFRESH trial will be lifted? I think this is priority. Big pharma doesn't rely on message boarders conviction for a medical device...yes, they'll need real data, let's forget Hemo-offend for now and produce some tangible results.
Kind of too bad that Lakers only gets 1 post per day, so knowledgeable and so much real info to share. This resrtiction shows the real face of the intent here to deceive and mislead. maybe the coiled spring is already stretched beyond repair?
FWIW
Hemopure/orangecat...I'm beginning to think you guys are one in the same along with many other promotors here. I'm getting out of 50% of my position or 100 shares for now. I'm concerned that 15 year old Hemo-offend is mentioned so much here. Is this just a place to push and promote stock? I find the fishing talk phony too. It wouldn't surprise me if you guys were crooked Canadians ... let's hope not! Family family Dr. Kevin was over for some fish and chips last night and warned me about internet fraud. Really it's now time to talk turkey or in this case science. I think people are growing tired of phony internet IDs telling everyone how wonderful the beads are without RCT backing. Talk is cheap, science with hard data and proven efficacy will rise above all bull. Let's see some completed RCT data and move this thing along. I'll consider supporting with even bigger purchases IF I like what I see in the way of efficacy. Nuff said!
Have to agree in regards to standard of care. The one small hurdle would be the importance of scientific backing from an official FDA RCT or randomized control trial for the newbies onboard. This product appears great and wonderful..but...it's the ability to show a marked difference against a placebo comparative arm that ultimately decides just how effective this process is. I remind readers that EUA designations during the pandemic are not the most difficult designation to obtain. In my humble opinion it was our lack of RCT data that ultimately drove FMC to cut us loose in the EU. A mistake on their part? ...the future will reveal..but not until we get the RCT data we need. Any word on the suspended REFRESH II here in the US? Chan had mentioned we were closing in on the required data needed to get this moving...this would go a long way towards firming up our scientific story..again in my humble opinion!
GLTA longs!
Hemo-offend news is large. Nice job watching over the story board Hemopure! I think this Mikesmith alter-ego might be in-line for a surprise of sorts. Hemo-offend has long been a Cyto fav of mine. Even family friend Dr. Kevin says if we get into a major conflict, Hemo-offend could serve our nation well. So many opportunities and contrary to what many are saying, getting a EUA for CV19 is not nearly as easy as most think. We are really starting to round into form here. Hemo-offend has been a product some 15 years in the making, it's no surprise it's starting to rise to the top like fresh cream! Excited and hoping to see a $10 spot today. GLTA!!! and nice pick up on the open with a 10 cent increase, you can't sneeze at 1% !!!
I'll take the hit on the decline. Whatever I buy usually drops with hours of my purchase. I picked up my 100 shares in the low $9's and here we are in the $8's. I'm sure it will come back though, especially once Hemo-offend shows it's true colors! I agree the markets seem awfully positive given the current social and economic environment. Best of luck to all the holders of this and other stocks. Peace be with you!
Lay off our leader, he is top notch! The real problem here is the real lack of proven efficacy by way of randomized control trials. In my opinion it`s why we lost Fresenius in the EU and why sales from the big boys have lagged...and that is kind. I`m not too sure how the many pretend docs and scientists assigned here all know the product is so wonderful. Based on what...how do message board people know what the real efficacy is without FDA trial backing
Magical product without much question. The more I learn about drug and device companies, the more I realize that randomized control trials are king. I would like to see this new drug removal strategy for cardiac get some RCT data under it's wings. Having witnessed the development of the Sorb and Hemo-offend, I believe it's the lack of solid data that has kept us back. The new doctor seems very intelligent and I'l bet he would agree that a RCT and a FDA stamp is the secret sauce to propel the magic beads! Almost saved enough for my next tranche of 100 shares here! Looking for registration on a phase 1/2 here in the US sooner rather than later. It would be exciting to see a successful trial complete with efficacy numbers! It's really nice of Orangey to share his personal experiences here on the CTSO network, very folksy of you and it really helps add to your already rock solid credibility as the gatekeeper of this wildly positive forum.
All the pieces are clearly in place. We have crazy apparent growth and strong convictions from a tight group of believers here on the internet that are likely our largest core group of retail holders. This sets up well, as the people posting here love it so much they post over and over again about just how good it is and just how well the product works! The next thing to look for is strong inside ownership conviction. Rather then selling the company ATM or at the market to strangers, the next step is to look for insiders and institutions taking large chunks. This is likely to happen sometime in the near to medium future. Furthermore, the suspended FDA trial is also likely to be re-started sometime in the near to medium future too as the Covid19 concerns subside. Once the the trial is re-started and all the good data starts flowing we'll see the Fresenius types return and likely start asking how do we buy this scientific marvel and how in the world did we let it get away from us years ago? The big boy pharmas aren't always as smart as everyone thinks, sometimes the internet investors know even more about the true usefulness or efficacy of a product just because they post so much and pay such close attention to all the data...likely the case here and that is why I'm saving for another 100 or possibly even more shares! GLTA
Good point and I agree. They only lost 19 million in 2019 so we are not that far from being profitable. Given the current FDA trial is suspended for some data collection concerns, we'll save a few mill there too. Add in the covid uptick and we are likely only going to lose about half of what we lost in 2019.
Where is Cesare74 and do you guys think he was a pumper plant? How culd he have shared all that positive Fresenius intel with us only to have them give CTSO back the European rights? I wonder whether the SEC is crawling up his slimy back?
I know we hook people up to our filter, like all day, how does this impact the dialysis equipment at the hospital and the urgent demands for this equipment with current AKI issues from Covid patients? I think we need our own delivery system to uptick more sales once we get a bigger facotry because so many people want to buy our filters.
Thanks Rob. This information is vital to us all, as was your Caesare74 EU intel. We are now 100%, give or take 80% to 90%, that you are in fact located in Florida and not Toronto Canada.
Did Cesare pass? If so, why didn't he get the send-off your Bertha character received?
This is a great product! Wonder why the FDA won't stamp it? It's a shame when the medical people put hard science in front of real world data! I still wonder why Fresenius gave up so easily on CTSO in Europe? It's mind boggling to say the least! Thank goodness we have such a stout and knowledgeable group of internet scientists that really know what is up! Did Cesare74 die too? Who remembers his famous lunches with the FMC person and the talk of the relationship with them launching like a bottle rocket? I'm confused now, I want more and am saving for a second tranche of 100 shares! Please keep up the pressure and maybe we'll never need a complete and successful RCT to get the sorb where it belongs! I think the US treatment numbers are lagging because we don't have easy access to the dialysis equipment. There is a huge shortage given the AKI issues with the severe CV19 survivors. Look to portable dialysis equipment as a solution. We should create our own blood pump to boost sorb uptake FWIW!! I think 400 might be more doable for now, 4,000 seems a stretch but only given the hardware delivery shortage! I'm feeling more optimistic with every passing lift towards those $15 previous highs! We should be at over a bill now!! Looking forward to hearing all about what Mexico adds to our bottom line!
This is a great product! Wonder why the FDA won't stamp it? It's a shame when the medical people put hard science in front of real world data! I still wonder why Fresenius gave up so easily on CTSO in Europe? It's mind boggling to say the least! Thank goodness we have such a stout and knowledgeable group of internet scientists that really know what is up! Did Cesare74 die too? Who remembers his famous lunches with the FMC person and the talk of the relationship with them launching like a bottle rocket? I'm confused now, I want more and am saving for a second tranche of 100 shares! Please keep up the pressure and maybe we'll never need a complete and successful RCT to get the sorb where it belongs! I think the US treatment numbers are lagging because we don't have easy access to the dialysis equipment. There is a huge shortage given the AKI issues with the severe CV19 survivors. Look to portable dialysis equipment as a solution. We should create our own blood pump to boost sorb uptake FWIW!! I think 400 might be more doable for now, 4,000 seems a stretch but only given the hardware delivery shortage! I'm feeling more optimistic with every passing lift towards those $15 previous highs! We should be at over a bill now!! Looking forward to hearing all about what Mexico adds to our bottom line!
Case studies and retrospective studies are largely laughed at in the world of science, just ask our family friend Kevin. Oxiris has little human data according to the slides. Toraymyxin had a phase II study stopped because it was working too well. You can ask Toray why they did not continue with the same group of patients in their phase III. Toraymyxin has earned FDA compassionate care approval here in the US. Toraymyxin is currently running a phase 3B confirmatroy trial where 2 patients get PMX and one gets standard of care. There is no comparison of the products. Toraymyxin has a FDA approved diagnostic to guide therapy. Soon SQIDF will produce a similar product for IL-6. This diagnostic will truly measure the effectiveness of Oxiris and the Sorb. Important to understand that endotoxin is the root of cytokines, removing the root is key, just like weeding. Spectral ownership is tight and strategy to fly under the radar and scrape the dirt has proven valuable to promote correct ownership. I own all three companies but EDTXF, the least advertised is the golden goose. GLTA and do some reading, EDTXF has a FDA IDE, the others an EUA....there is a big difference. It is better, what is IT? Cousin IT? Approval from the FDA or retropective Indian data?? So hard to know where to place your bet LOL
Hope is not the best business strategy. Look at the results from the German sepsis RCT. It was a disaster and I don't recall any other formal RCT for Sepsis since. I enjoyed the commentary on the EDTXF revenue. The company chose not to book the 5 million from Baxter as immediate revenue. EDTXF does the opposite of everything CTSO does. This would include the insiders and their partners owning virtually all the stock along with extensive FDA trial work and the subsequent IDE approval for covid19 instead of the garden variety EUA.... Hmmmmmm?
I think the right people care. People ensuring CTSO is promoted and EDTXF is buried. I think Baxter cares and so does the FDA. We all appreciate the interest from message board employees, my concern here would be why Fresenius chose to cut ties with CTSO in Europe and why they never did a deal in Germany, their home and native land. Maybe Dr. Patrick the chief of staff from Canada can find time to comment on that?
Where is the data from that German Sepsis study anyway????
The advancement of the beads begs the question posed by the 880LB gorilla in the room. Did Fresenius make a huge error in letting go of their strangle hold on the beads in the EU? Why would Fresenius have let this apparent miracle device slip through their fingers in such key markets in the EU? Especially in their own backyard, Germany? They never did have any deal in Germany and the balance of the key EU countries were handed back to Cyto...WHY? Glad to see Lowebrau has been removed as a moderbater, about time that got fixed!
Your list should include Baxter's partner Spectral Medical EDTXF. Unlike the EUAs being tossed around like bean bags, EDTXF achieved an IDE...look it up boss.
Spectral Medical, Aethlon and Cytsorbent. I know quite a bit about all three of these filtration plays with unique bonds to one another. Spectral is the most advanced and I would place AEMD firmy in the 2 hole from an FDA advancement standpoint. CTSO has by far ans away the most revenue but I feel this is by design. Their US FDA advancement remains limited and the amount of promotion remains over the moon. I would like to see AEMD and EDTXF form a partnership, I feel they would benefit one another in a large way. The posting on this message board and the CTSO is tied together, it's the same people working the public. One more thing, the WE'RE NO LONGER SUSPENDED BY THE SEC welcome wagon message needs to go. That said it is another reason to love something that is obviously not designed to be loved!
Next generation looks exciting. Hemodefend and Sorb XL will be huge in the coming months, potentially. It may be prudent to RCT these important new products so that efficacy can be provided in hopes of securing some of the big-boys and their distribution capability. Hemodefend has been in the pipeline for about 15 years so it's ripe for commercialization to be sure. For me personally the future of this surging giant is in the Ticegrelor area. I like the sounds of that initiative and I really like this new Greek doctor. I will say that just like the Sorb et al stable of products we do need to get on the RCT track quick and early so that majors take notice and have backing to move our product. The medical industry is entirely based in Missouri, it's all about showing the market what the science has to offer.
Spectral is further down the road than any other filtration play. Likely why Baxter chose their product to market. Endotoxin is the primary source of the cytokine storm and Toray of Japan's PMX or Toraymyxin is the best remover of endotoxin on the market. Furthermore, PMX has a FDA approved assay to fully guide usage and effectiveness and Spectral has a FDA approved portable device to administer PMX. With the heavy need for dialysis continuing in the ICU setting, dialysis equipment is and will be at a premium. The EUAs issued to Baxter and Cyto are nice, but the IDE issued to Spectral for PMX is the result of years of FDA study and consultation. People seem to be oblivious to the fact that EDTXF earned compassionate care approval for PMX years ago. Look for an approval from SQI or SQIDF of Toronto Canada in the coming days or weeks. They will produce a valuable tool to measure the cytokine storm and specifically IL-6 so that treatment may be monitored for efficacy. This where the rubber hits the roads people, we'll soon see just how effective our beads are, I'll bet they prove to be absolutely wonderful. Chan should hook up with SQIDF so that we have a theragnostic solution!
Cybo-sordent was the company the caller from Cali was dialing in on. It would seem unusual that an investor would be passionate enough to call in to Cramer and not have a clue how to pronounce the name of the company he was asking about. Listen to the video, very perplexing, either Chris is a surfer dude or Chris has a list. One thing for certain, Chris is not Chief of Staff material, even if like our friend in Canada his staff amounts to 2 or less. Should be a great day despite the blown Cramer attempt! Most people that buy as the result of a 30 second spot on TV aren't likely to catch the Cybo-sordent slip up. The crowd you really want are those impressed with big data and that is clearly on the way! GO CTSO GO!
Canadian message boards talking up AEMD and wishing for potential arrangement with FDA advanced and Baxter partner Spectral Medical. Doesn't trade here in the US other than once and awhile on otc. They are looking at a US listing now and have wonderful science and portable dialysis equipment to deliver filtration. Why is AEMD only a fraction of CTSO? I like the science here and FT with FDA! There must be 6 to 8 million in cash too, almost half the company value!!!!!!!1
Swingers trading may prove erroneous. I read the transcript and towards the very end the CEO said that , "data was coming"...in my opinion the missing link in this puzzling medical miracle! Just imagine some real hard core data coming from a randomized trial! It's just like Dr. Hahn said during a task force update...we need RCT proof with the proposed treatment displaying the true benefits against the placebo or SOC. If we get this and soon, I am expecting a surge back to the old highs of $15 and greater. Speaking of old highs, anyone remember what took the stock to over $15 a few short years ago? Was it rumor of a takeover or some other form of rumor? Nice to have it right there on the chart as a place we've already been, regardless of how we got there! The Mexican comment was verging on racist, so one of the 10 moderators should remove this comment. Why do we have 10 moderators and why is Dr. Lowenbrau on the list, doesn't he pretend to be anti-sorb? Lowenbrau seemed knowledgeable on the FDA advanced Spectral though. I would like to see EDTXF and AEMD hitch their wagons together. I love multi nation plays! Why is Toronto Raptor Rob calling CTSO a P & D? He should listen to the transcript! Even Cowen talked up the FDA from our "competitor", Dr. Phil chose not to comment. Where is my moderator badge? I applied over 3 weeks ago and have not heard back! You could use my insight around here, I know more about hemoperfusion and such than anyone else, except maybe the chief of staff, the pretend doctor.
Responding to the dementia chief of staff. You do know it is illegal to place the Dr. in front of your name if in fact it's not the truth? Maybe Christien should properly identify the people he is responding to online. Canadians may be gullable, but I'm pretty sure they understand the difference between internet stock promotion and a real doctor. Does chief of staff refer to a staff of 1? You gents should go easy on some of this bs, it taints an otherwise believable forum. I hope you find benefit in this suggestion. I hope the dementia major isn't the only Canadian lobbyist for the beads. If so, I would place more focus on Latin America, I do not believe Canada will buy what the dementia chief of staff is selling. Just my opinion
The Vancouver Dementia Center? Hmmm I like the validation from this Canadian Covid19 hotspot. They claim "excellent" results, I'm surprised Canada has not bitten down on this. They are nice peoples but a little gullable at times I have noticed. I wonder whether their health system needs more than safety to approve something...let's hope not! I like this new appointment of a doctor. Didn't the last one leave when the FDA suspended our trial? Good to see this did not deter the new doc!
The introduction of SQI from Canada. WOW so cooool! Oh look a Canadian company with a soon to be FDA approved measuring tool for IL-6 and the potential advancement of a move for CTSO towards a theranostic approach. What a concept...and to think that SQI was founded by the head scientist from Spectral in 1999....insert Disney's It's a small world here. Baxter and CTSO at same level with EUA approval...Spectral or EDTXF somewhere a storey or two higher with FDA IDE, FDA diagnsotic to guide and FDA SAMI portable pump to administer. I love a good coin-cidence. There is nothing wrong with making a little money while the opening band is performing.